Financials
- Market Capitalization 47.94 B
- Employee 33 K
- Founded N/A
- CEO Richard Francis
- Website www.tevapharm.com
- Headquarter Israel
- FIGI BBG000C0CD58
- Industry Fabricantes de medicamentos — especializados y genéricos
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
25.79
Relación precio/flujo de caja
2.1
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 356 | HLN Haleon plc American Depositary Shares | 9.51 USD | +2.15% | +6.26% | +1.28% | +4.16% | 42.57 B USD | ||
| 433 | ZTS Zoetis Inc. Class A Common Stock | 75.64 USD | +1.16% | +5.29% | +1.87% | -48.31% | 31.26 B USD | ||
| 450 | TAK Takeda Pharmaceutical Company Limited American Depositary Share | 18.69 USD | -0.21% | +3.78% | +0.70% | +31.76% | 29.11 B USD | ||
| 574 | VTRS Viatris Inc. - Common Stock | 17.54 USD | -0.57% | -1.46% | +5.22% | +69.47% | 20.15 B USD |